Opioid Use and Misuse Resource Center

APhA believes it is imperative that a proper balance be maintained in delivering appropriate pain management for the millions of patients with legitimate needs for controlled substances while taking steps to minimize misuse.  Pharmacists possess unique knowledge about the safe and effective use of medications and about the adverse events resulting from inappropriate use. Such knowledge enables pharmacists to play an important role in patient access to opioids, but also opioid drug misuse prevention, education, and assistance.  

Opioid News
July 27, 2020
FDA requires naloxone info on opioid labels

The labeling changes, which were unveiled in an FDA Drug Safety Communication, advise that health professionals consider prescribing naloxone when they prescribe medicines for OUD or when prescribing opioids to individuals who are at an increased risk of an opioid overdose. Additionally, a…

Read More
April 28, 2020
APhA coronavirus watch: Maintaining access to care for patients with chronic pain, OUD during pandemic

“As with other medications for other chronic conditions, hoarding, closed pharmacies, and unknown future limitations on medication production limit access,” said Jeffrey Bratberg, PharmD, FAPhA, clinical professor at the University of Rhode Island College of Pharmacy and an expert on substance use…

Read More
March 10, 2020
Pharmacist prescribing of naloxone improves access to life-saving medication

“Legal barriers needed to be removed to address this important public health crisis. Pharmacists positively impact the health of patients every day and work tirelessly to address the opioid epidemic. By providing naloxone, pharmacists save lives,” said lead study author Neha Gangal, a PhD candidate…

Read More
February 10, 2020
More than one-half of dental prescriptions for opioids exceed recommended guidelines

The findings also showed that 29% of dental patients received more powerful opioids than needed for expected postprocedure pain. "Unlike national trends, opioid overprescribing by dentists is increasing,” said lead study author Katie J. Suda, PharmD, MS, a professor at the University of Pittsburgh…

Read More
February 4, 2020
Buprenorphine treatment lags for younger patients with opioid use disorder

“While it’s encouraging to see an overall increase in prescription rates for buprenorphine, the data suggest that the youngest group is having difficulty accessing this potentially lifesaving treatment,” said lead study author Mark Olfson, MD, MPH, the Elizabeth K. Dollard professor of psychiatry,…

Read More
January 23, 2020
Evidence Based Practice: Podcast and Literature Series

APhA has partnered with iForumRx, an interactive web-based community for Ambulatory Care pharmacy specialists, to produce a line of innovative and interactive recertification products. This series will feature succinct commentaries about practice-changing evidence through a series of podcasts,…

Read More